Peter Devine is CEO of Uniseed and has extensive experience at board and executive management levels in the commercialisation of early-stage technologies, having held senior R&D, business development and commercialisation positions in a number of Australian companies and Australian universities. Has served on the Board of numerous start-ups which have collectively raised over AU$290 million, with a number of these were successfully sold to large multi-nationals in deals collectively worth over AU$1.75 Billion. Recent successes include Fibrotech Therapeutics' sale to Shire in 2014; the Spinifex Pharmaceuticals sale to Novartis in 2015; and the Hatchtech sale to Dr Reddy's in 2015.
CEO of Uniseed since 2006, taking on the management of Uniseed’s second fund of $40 million, which provided a number of high profile exits. Uniseed started its third fund in March 2016, a $50 million partnership between the Universities of Queensland, NSW, Sydney and Melbourne, and the CSIRO. A $20 million follow-up fund was announced in early 2017.
Peter has extensive experience at board and executive management levels in the commercialisation of early-stage technologies, having held senior R&D, business development and commercialisation positions in a number of Australian companies and Australian universities.
Peter was VP of Business Development at ASX-listed Progen Industries Ltd. He was Research, Development and Commercialisation Manager at Brisbane-based PanBio Pty Ltd from 1996 to 2000, which ultimately was sold to Inverness Medical.
Peter had a distinguished career in academic research, being the recipient of a number of competitive grants, which resulted in numerous patents, publications and scientific presentations at conferences.
Received the Dean’s Prize and the AGSM Alumni Scholarship for his MBA Studies at the Australian Graduate School of Management.
Received a Centenary Medal in 2003 for outstanding contribution to the business of biotechnology.
Peter is a Graduate and Fellow of the Australian Institute of Company Directors and holds a Diploma of Financial Services (Financial Markets) and a Graduate Diploma in Applied Finance from Kaplan Professional.
In 2011 & 2012, Peter was named on the Kaplan High Achievers Honour Roll.